316 related articles for article (PubMed ID: 17176368)
1. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
Song DK; Zhao J; Zhang LR
J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368
[TBL] [Abstract][Full Text] [Related]
2. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
3. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M
Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
[TBL] [Abstract][Full Text] [Related]
4. Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.
Aghdaie MH; Azarpira N; Geramizadeh B; Sagheb M; Darai M; Rahsaz M; Malekhoseini SA
Exp Clin Transplant; 2011 Aug; 9(4):241-6. PubMed ID: 21819368
[TBL] [Abstract][Full Text] [Related]
5. The impact of thiopurine S-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation.
Fabre MA; Jones DC; Bunce M; Morris PJ; Friend PJ; Welsh KI; Marshall SE
Transpl Int; 2004 Oct; 17(9):531-9. PubMed ID: 15349717
[TBL] [Abstract][Full Text] [Related]
6. Determination of intra-ethnic differences in the polymorphisms of thiopurine S-methyltransferase in Chinese.
Zhang JP; Zhou SF; Chen X; Huang M
Clin Chim Acta; 2006 Mar; 365(1-2):337-41. PubMed ID: 16223474
[TBL] [Abstract][Full Text] [Related]
7. [Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].
Zhan ZP; Liang LQ; Yang XY; Wang YX; Huang M; Li H
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1734-7. PubMed ID: 17919375
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of thiopurine S-methyltransferase in Argentina.
Laróvere LE; de Kremer RD; Lambooy LH; De Abreu RA
Ann Clin Biochem; 2003 Jul; 40(Pt 4):388-93. PubMed ID: 12880540
[TBL] [Abstract][Full Text] [Related]
9. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism.
Boonsrirat U; Angsuthum S; Vannaprasaht S; Kongpunvijit J; Hirankarn N; Tassaneeyakul W; Avihingsanon Y
Lupus; 2008 Feb; 17(2):132-4. PubMed ID: 18250137
[TBL] [Abstract][Full Text] [Related]
10. Frequency of the thiopurine S-methyltransferase alleles in the ancient genetic population isolate of Sardinia.
Rossino R; Vincis C; Alves S; Prata MJ; Macis MD; Nucaro AL; Schirru E; Congia M
J Clin Pharm Ther; 2006 Jun; 31(3):283-7. PubMed ID: 16789994
[TBL] [Abstract][Full Text] [Related]
11. Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans.
Loennechen T; Yates CR; Fessing MY; Relling MV; Krynetski EY; Evans WE
Clin Pharmacol Ther; 1998 Jul; 64(1):46-51. PubMed ID: 9695718
[TBL] [Abstract][Full Text] [Related]
12. [Thiopurine S-methyltransferase gene polymorphism in Chilean blood donors].
Alvarez L L; Venegas S M; Larrondo L M; Becerra B N; Castro L A; Quera P R
Rev Med Chil; 2009 Feb; 137(2):185-92. PubMed ID: 19543639
[TBL] [Abstract][Full Text] [Related]
13. An audit of thiopurine methyltransferase genotyping and phenotyping before intended azathioprine treatment for dermatological conditions.
Vestergaard T; Bygum A
Clin Exp Dermatol; 2010 Mar; 35(2):140-4. PubMed ID: 19663853
[TBL] [Abstract][Full Text] [Related]
14. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.
Vannaprasaht S; Angsuthum S; Avihingsanon Y; Sirivongs D; Pongskul C; Makarawate P; Praditpornsilpa K; Tassaneeyakul W; Tassaneeyakul W
Clin Ther; 2009 Jul; 31(7):1524-33. PubMed ID: 19695401
[TBL] [Abstract][Full Text] [Related]
15. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
Dokmanovic L; Urosevic J; Janic D; Jovanovic N; Petrucev B; Tosic N; Pavlovic S
Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine S-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients.
Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Syriopoulou VP; Goutas N; Vlachodimitropoulos D; Anagnou NP; Roma-Giannikou E
J Clin Pharm Ther; 2010 Feb; 35(1):93-7. PubMed ID: 20175817
[TBL] [Abstract][Full Text] [Related]
17. Allelic variants of the thiopurine S-methyltransferase deficiency in patients with ulcerative colitis and in healthy controls.
Corominas H; Domènech M; González D; Diaz C; Roca M; García-González MA; Peña S; Baiget M
Am J Gastroenterol; 2000 Sep; 95(9):2313-7. PubMed ID: 11007234
[TBL] [Abstract][Full Text] [Related]
18. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.
Snow JL; Gibson LE
Arch Dermatol; 1995 Feb; 131(2):193-7. PubMed ID: 7857117
[TBL] [Abstract][Full Text] [Related]
19. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV
J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783
[TBL] [Abstract][Full Text] [Related]
20. Thiopurine S-methyltransferase genetic polymorphism in the Thai population.
Srimartpirom S; Tassaneeyakul W; Kukongviriyapan V; Tassaneeyakul W
Br J Clin Pharmacol; 2004 Jul; 58(1):66-70. PubMed ID: 15206995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
